Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

ASH 2019 Relapsed Myeloma Highlights: Can Biomarkers Predict Response to Venetoclax, Venetoclax Combinations, CAR T Trials & Anti-BCMA CAR T-cell Therapy

133 views
March 9, 2020
Comments 0
Login to view comments. Click here to Login